Biopharmaceutical Analysis & Statistics, November 2014 (p20)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

571-600 of about 1 900 reports

Purchase Reports From Reputable Market Research Publishers

BioMedical Technology Solutions Holdings, Inc. - Strategic SWOT Analysis Review

BioMedical Technology Solutions Holdings, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary BioMedical Technology Solutions Holdings, Inc. (BMTS) is a waste management company, based in the US. The company provides solutions for environmentally friendly disposal of biomedical waste. It ...

Dendritic Cell and CAR-T Therapies Market, 2014 - 2024

Dendritic Cell and CAR-T Therapies Market, 2014 - 2024

  • $ 1 899
  • Industry report
  • November 2014
  • by Roots Analysis Private Ltd.

INTRODUCTION Cancer is known to be one of the leading causes of death worldwide. The field of oncology is vast and comprises several indications, including some rare / orphan forms. Although oncology continues ...

  • Industries : Pharmaceutical, Biological Therapy, Therapy, Biotechnology, Motor Vehicle, Pathology, Hospitality, Hospitality, Automotive
  • Countries : United States
Global Oncology Biosimilars Market 2014-2018

Global Oncology Biosimilars Market 2014-2018

  • $ 2 500
  • Industry report
  • November 2014
  • by Infiniti Research Limited

About Oncology Biosimilars Biosimilars are follow-on versions of biological medicines that are developed after the expiry of the patent protection on the original product. Biosimilar medicines have a mechanism ...

  • Industries : Generic Drug, Pharmaceutical
  • Countries : World
Physician Views: Will next-generation long-acting insulins prove compelling?

Physician Views: Will next-generation long-acting insulins prove compelling?

  • $ 681
  • Industry report
  • November 2014
  • by Firstword Pharma

In the second of two diabetes-focused Physician Views polls being run by FirstWord Pharma PLUS this week (see also Physician Views: What opportunity for biosimilar basal insulin?), we are polling US and ...

  • Industries : Biopharmaceutical
  • Countries : Europe
China Recombinant Protein Drug Industry Report, 2014-2017

China Recombinant Protein Drug Industry Report, 2014-2017

  • $ 2 500
  • Industry report
  • November 2014
  • by Research In China

The Chinese recombinant protein drug market has been expanding rapidly owing to the improvement of demand rigidity, consumption ability and the like. During 2005-2013, sales of recombinant protein drugs ...

  • Industries : Drug and Medication
  • Countries : China
Ipsen Biopharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Ipsen Biopharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary Ipsen Biopharmaceuticals, Inc., (Ipsen), formerly known as Tercica, Inc., is a biotechnology company. It identifies and commercializes products in therapy areas such as, endocrinology and neurology. ...

  • Industries : Biopharmaceutical
Keryx Biopharmaceuticals, Inc. (KERX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Keryx Biopharmaceuticals, Inc. (KERX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary Keryx Biopharmaceuticals, Inc. (Keryx) is a biopharmaceutical company, It is engaged in acquiring, developing and commercializing pharmaceuticals products.Currently the company’s only product ...

  • Industries : Biopharmaceutical, Pharmaceutical
Hypoglycemia - Pipeline Review, H2 2014

Hypoglycemia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Hypoglycemia - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Hypoglycemia - Pipeline Review, H2 2014’, provides an overview of the Hypoglycemia’s therapeutic pipeline. This report ...

  • Industries : Pathology, Pharmaceutical, Biopharmaceutical
  • Countries : United States
Epstein-Barr Viral Infections - Pipeline Review, H2 2014

Epstein-Barr Viral Infections - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Epstein-Barr Viral Infections - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Epstein-Barr Viral Infections - Pipeline Review, H2 2014’, provides an overview of the Epstein-Barr Viral ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Fabry Disease - Pipeline Review, H2 2014

Fabry Disease - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Fabry Disease - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Fabry Disease - Pipeline Review, H2 2014’, provides an overview of the Fabry Disease’s therapeutic pipeline. This report ...

  • Industries : Pathology, Pharmaceutical, Drug and Medication
  • Countries : United States
Grass Pollen Allergy - Pipeline Review, H2 2014

Grass Pollen Allergy - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Grass Pollen Allergy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Grass Pollen Allergy - Pipeline Review, H2 2014’, provides an overview of the Grass Pollen Allergy’s therapeutic ...

  • Industries : Drug and Medication, Pharmaceutical
  • Countries : World
Enterovirus Infections - Pipeline Review, H2 2014

Enterovirus Infections - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Enterovirus Infections - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Enterovirus Infections - Pipeline Review, H2 2014’, provides an overview of the Enterovirus Infections’s therapeutic ...

  • Industries : Pathology, Drug and Medication, Biopharmaceutical, Pharmaceutical, Biotechnology
  • Countries : World, China
West Nile Virus Infections - Pipeline Review, H2 2014

West Nile Virus Infections - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

West Nile Virus Infections - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘West Nile Virus Infections - Pipeline Review, H2 2014’, provides an overview of the West Nile Virus Infections’s ...

  • Industries : Biopharmaceutical, Drug and Medication, Research and Development, Pathology, Pharmaceutical
  • Countries : United States
Infectitious Diarrhea - Pipeline Review, H2 2014

Infectitious Diarrhea - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Infectitious Diarrhea - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Infectitious Diarrhea - Pipeline Review, H2 2014’, provides an overview of the Infectitious Diarrhea’s therapeutic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Ragweed Allergy - Pipeline Review, H2 2014

Ragweed Allergy - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Ragweed Allergy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Ragweed Allergy - Pipeline Review, H2 2014’, provides an overview of the Ragweed Allergy’s therapeutic pipeline. This ...

  • Industries : Biopharmaceutical, Drug and Medication, Pharmaceutical
  • Countries : World, United States
Male Infertility - Pipeline Review, H2 2014

Male Infertility - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Male Infertility - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Male Infertility - Pipeline Review, H2 2014’, provides an overview of the Male Infertility’s therapeutic pipeline. ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : World
Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2014

Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2014’, provides an overview of the Microscopic Polyangiitis ...

  • Industries : Pathology, Pharmaceutical, Biopharmaceutical
  • Countries : World, United States
Wegener%s Granulomatosis - Pipeline Review, H2 2014

Wegener%s Granulomatosis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Wegener's Granulomatosis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Wegener's Granulomatosis - Pipeline Review, H2 2014’, provides an overview of the Wegener's Granulomatosis’s ...

  • Industries : Pathology, Pharmaceutical
  • Countries : World
Fusion Antibodies Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Fusion Antibodies Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary Fusion Antibodies Ltd (Fusion Antibodies) is a contract research organization (CRO). It holds expertise and offers contract services in the production of monoclonal antibodies, antibody sequencing, ...

  • Industries : Biopharmaceutical
Breast Cancer - Pipeline Review, H2 2014

Breast Cancer - Pipeline Review, H2 2014

  • $ 2 500
  • Industry report
  • November 2014
  • by Global Markets Direct

Breast Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H2 2014’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report ...

  • Industries : Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Rheumatoid Arthritis - Pipeline Review, H2 2014

Rheumatoid Arthritis - Pipeline Review, H2 2014

  • $ 2 500
  • Industry report
  • November 2014
  • by Global Markets Direct

Rheumatoid Arthritis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H2 2014’, provides an overview of the Rheumatoid Arthritis’s therapeutic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Pancreatic Cancer - Pipeline Review, H2 2014

Pancreatic Cancer - Pipeline Review, H2 2014

  • $ 2 500
  • Industry report
  • November 2014
  • by Global Markets Direct

Pancreatic Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H2 2014’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Hepatocellular Carcinoma - Pipeline Review, H2 2014

Hepatocellular Carcinoma - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Hepatocellular Carcinoma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Hepatocellular Carcinoma - Pipeline Review, H2 2014’, provides an overview of the Hepatocellular Carcinoma’s ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Gastric Cancer - Pipeline Review, H2 2014

Gastric Cancer - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Gastric Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H2 2014’, provides an overview of the Gastric Cancer’s therapeutic pipeline. This report ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Hepatitis B - Pipeline Review, H2 2014

Hepatitis B - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Hepatitis B - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Hepatitis B - Pipeline Review, H2 2014’, provides an overview of the Hepatitis B’s therapeutic pipeline. This report provides ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2014

Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2014’, provides an overview ...

  • Industries : Pathology, Pharmaceutical, Biopharmaceutical
  • Countries : United States
Haemophilus Influenzae Type b Infections - Pipeline Review, H2 2014

Haemophilus Influenzae Type b Infections - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Haemophilus Influenzae Type b Infections - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Haemophilus Influenzae Type b Infections - Pipeline Review, H2 2014’, provides an overview of ...

  • Industries : Pathology, Biopharmaceutical, Drug and Medication, Pharmaceutical, Biotechnology
  • Countries : China, World
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Review, H2 2014

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline ...

  • Industries : Pathology
  • Countries : United States
Chlamydia Infections - Pipeline Review, H2 2014

Chlamydia Infections - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Chlamydia Infections - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Chlamydia Infections - Pipeline Review, H2 2014’, provides an overview of the Chlamydia Infections’s therapeutic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Idiopathic Juvenile Arthritis (Still%s Disease) - Pipeline Review, H2 2014

Idiopathic Juvenile Arthritis (Still%s Disease) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Idiopathic Juvenile Arthritis (Still's Disease) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Idiopathic Juvenile Arthritis (Still's Disease) - Pipeline Review, H2 2014’, provides ...

  • Industries : Pathology, Pharmaceutical
  • Countries : World, United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.